Evenamide Hydrochloride

N/A

Report date: 2026/03/13 20:02:36
NME

Base Information

Drug NameEvenamide Hydrochloride
Drug Alias Name依文酰胺Evenamida依维那胺EvenamidumNW-3509 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel protein type III alpha subunit blockersSodium channel protein type X alpha subunit blockersSodium channel protein type IX alpha subunit blockers
TargetsSodium channel protein type IX alpha subunitSodium channel protein type III alpha subunitSodium channel protein type X alpha subunit
Therapy Area/IndicationsSchizophreniaMental Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesItalyUnited Kingdom +[4] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesNewron Pharmaceutical
China Registration ClassN/A

Develop Information

Active CompaniesEa Pharma Co LtdNewron Pharmaceuticals SpaMyung In Pharm Co Ltd
Inactive CompaniesN/A
Active IndicationsSchizophreniaMental Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipedia